Lombard Medical, Inc. announced preliminary revenue results for the fourth quarter and full year ended December 31, 2014. Total revenue for the year was $13.3 million increased 91% as compared to $7.0 million in 2013. 2013 total revenue included $0.8 million of contributions from the company's OEM business, which was divested in December 2013.

Global Aorfix revenue for the fourth quarter of 2014 grew 128% to $4.8 million as compared to the prior year period.

The company provided revenue guidance for the full year 2015. The company estimates that the number of Aorfix procedures in its four markets (US, Japan, Germany, UK) will more than double in 2015 as compared to 2014 and that pricing will remain stable in those markets. That growth is expected to yield 2015 global revenue of between $18 million and $20 million.